Purchase Order 75N93023P01041
Award Date
8/10/23
Potential Completion Date
12/31/23
Potential Value
$120K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Kemp Proteins, LLC
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21704, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order for $6,392.00 awarded by the Food and Drug Administration (FDA) to Kemp Proteins, LLC (doing business as Kempbio), a small disadvantaged business manufacturer of biological products. The contract is for baculovirus protein expression services to support FDA research initiatives. Kempbio has previously received over $300,000 in prime federal contracts from agencies like the National Institutes of Health (NIH) and Department of Agriculture for various gene...
This $89,239.94 firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Kemp Proteins, LLC (doing business as Kempbio), a small disadvantaged business. The contract is for the production of monoclonal antibodies and is set aside for small businesses. Kempbio is a provider of gene to protein bioservices, including protein expression, gene synthesis, cloning, and other research support services. The company has been awarded over $300,000 in prior prime federal...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $20,000 firm fixed price purchase order to Genscript USA Inc. to provide custom gene synthesis services. The contract will support NIH's research efforts at its Bethesda, Maryland campus through December 31, 2023. Genscript will deliver custom gene synthesis products to NIH researchers as part of the Institute's work to advance understanding of diseases...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $17,709 purchase order to Genscript USA Inc. to provide custom gene synthesis and expression services in support of its research efforts. The firm fixed price contract has a period of performance from September 18, 2023 through December 31, 2023 and will be carried out by Genscript at its facility located in Bethesda, Maryland. No major subcontractors or set aside designations were identified....
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $250,000 firm fixed price purchase order to Genscript USA Inc. of Piscataway, New Jersey. The order is for gene production and protein expression services to support the agency's research efforts. Services include gene synthesis, cloning, plasmid preparation, and protein expression and purification. The sole source award was negotiated under the authority of 41 U.S.C. 1901(a)(1) based on...
<p>This is a $5,900.00 firm fixed price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Kempbio, Inc. The contract is for the 20L baculovirus expression of TFIIH with HTS production, to be delivered FOB destination. The contract did not utilize a set-aside. The ultimate completion date is September 19, 2013.</p>
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $20,827.75 purchase order to Genscript USA Inc. to provide customized protein production using a baculovirus expression system. Performance will take place in Piscataway, New Jersey over a period of approximately three months concluding in mid-December 2023. The firm fixed price contract calls for Genscript to deliver the requested proteins without further...
This is a federal contract award from the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Kapa Biosystems, Inc. The contract is for the procurement of probes and shipping, with a firm-fixed price of $36,329.75 and a completion date of October 26, 2018. Kapa Biosystems, Inc. is a for-profit manufacturer of goods, including reagents, kits, and other scientific supplies to support genomic research, DNA...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $18,225 purchase order to Life Technologies Corporation for EXPIFECTAMINE transfection reagent kits. The fixed-price contract runs from August 31, 2023 through November 30, 2023 for delivery of the 10-liter kits to a facility in Grand Island, New York. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $34,697.53 firm fixed price purchase order to Genscript USA Inc. to provide DNA services in support of vaccine development efforts. Under the contract, Genscript will deliver gene synthesis, VectorArk cloning, and express plasmid preparation services. These services will enable the creation of peptide and protein immunogens as well as DNA constructs containing...